Tue, Nov 3, 2026 12:33 PM
Egis Pharmaceuticals PLC and the Faculty of Pharmacy of the University of Pécs have signed a cooperation agreement to support the practical training of pharmacy students and strengthen joint educational and scientific activities. The partnership aims to bring academic and industry expertise closer together, contributing to modern pharmacy education and the development of the next generation of pharmaceutical professionals in Hungary. More
Feb. 27.

Dr Csaba Pácz confirmed as Commercial Director of Egis Group

The selection process for the position of Egis Group’s Commercial Director has been closed. As a result, dr Csaba Pácz remains head of the Commercial Directorate.

More
Feb. 19.

Celebrating our company’s 110th anniversary

The predecessor of Egis Pharmaceuticals PLC, Dr Wander Pharmaceuticals and Nutriments Ltd. was registered on 19 February 1913.

More
Jul. 05.

Csaba Poroszlai is CEO of Egis Pharmaceuticals PLC

Csaba Poroszlai is confirmed CEO of the company by the Board of Directors of Egis. Balázs Vándor is appointed to the position of the Company’s Chief Financial Officer.

More
Apr. 11.

Egis Pharmaceuticals PLC for Ukraine

Since the very beginning of the war in Ukraine, Egis Pharmaceuticals PLC has been committed to helping and supporting those in need in all possible ways.

More
Mar. 08.

Egis Pharmaceuticals PLC helps its employees from Kyiv and offers further humanitarian aid worth more than HUF 100 million

Egis has been present in Ukraine for more than 20 years – its representative office has become an important player for supplying the country with medicines since its opening in 1999. Egis helps its colleagues in Ukraine in every way it can and provides humanitarian aid to Ukrainian patients in the current situation.

More
Mar. 02.

Our Ukrainian colleagues: safe in Hungary

Standing together has never been so crucial for the Egis family than in these difficult times.

More
Oct. 15.

Egis Inaugurates Two New Plants in Körmend

Two technology-intensive developments, carried out with state subsidies, were completed at Egis Pharmaceuticals PLC’s Körmend site (Hungary). The investments were inaugurated by Péter Szijjártó, Minister of Foreign Affairs and Trade, and by the company’s CEO, Dr. István Hodász on 15 October.  In addition to a new packaging plant, Egis has also established a plant with special knowledge and technology requirements, typically suitable to manufacture oncology products.  Thus, Egis is now able to implement all value-creating processes within the field of oncology, from development to active ingredient and finished product manufacturing.

More
Mar. 08.

A Decade-Long Commitment to the Treatment of Cancer

We have commemorated World Cancer Day.

More
Jan. 28.

Egis Celebrates 20th Anniversary in Vietnam

Egis today is among the Top50 foreign companies operating in Vietnam.

More
Jan. 22.

Pharmaceutical industry is one of the key players of the Hungarian economy

The performance of the Hungarian pharmaceutical industry in the last ‘peaceful year’ before the coronavirus epidemic was reviewed in a comprehensive analysis by Nézőpont Institute on behalf of 16 pharmaceutical companies of the Hungarian Pharmaceutical Manufacturers Association (MAGYOSZ).

More
Dec. 22.

Hand sanitizer stations – for the safety of pharmacists and patients

Disinfection plays an important role in reducing the risk of infection. As a responsible company, Egis supports the safe operation of pharmacies in the second wave of the coronavirus pandemic as well.

More
WarningYour browser is out of date. Please, use an updated version! Chrome || Firefox